Functional Remediation for Bipolar Disorder
A Pilot Study of Functional Remediation for Bipolar Disorder: Feasibility and Preliminary Efficacy
1 other identifier
interventional
30
1 country
1
Brief Summary
Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 17, 2017
CompletedFirst Submitted
Initial submission to the registry
January 11, 2018
CompletedFirst Posted
Study publicly available on registry
January 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2018
CompletedFebruary 28, 2019
February 1, 2019
1.1 years
January 11, 2018
February 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility
Feasibility will be determined by a composite of ability to recruit and deliver the treatment intervention to both cohorts of participants, with adequate delivery of the intervention as measured by completion of the manual's objectives.
30 weeks
Acceptability (Subject Satisfaction)
Acceptability of the intervention will be measured by use of the Satisfaction with Therapy and Therapist Scale.
30 weeks
Acceptability (Subject completion)
Measured by percentage of subjects who complete the intervention.
30 weeks
Secondary Outcomes (1)
Functional Impact
30 weeks
Study Arms (1)
Receiving Psychosocial Intervention
EXPERIMENTALFunctional Remediation: The functional remediation program consists of 21 weekly sessions, each lasting 90 min. This intervention addresses neurocognitive issues such as attention, memory and executive functions, but it focuses even more on enhancing functioning in daily routine. The content of the intervention is based on ecological tasks to be performed in two settings, in the clinic as well as at home. Participants will be trained with exercises for memory, attention, problem solving and reasoning, multitasking and organization in order to improve their functional outcome. Most of the techniques are based on paper-and-pencil tasks and group activities.
Interventions
Functional Remediation: The functional remediation program consists of 21 weekly sessions, each lasting 90 min. This intervention addresses neurocognitive issues such as attention, memory and executive functions, but it focuses even more on enhancing functioning in daily routine. The content of the intervention is based on ecological tasks to be performed in two settings, in the clinic as well as at home. Participants will be trained with exercises for memory, attention, problem solving and reasoning, multitasking and organization in order to improve their functional outcome. Most of the techniques are based on paper-and-pencil tasks and group activities.
Eligibility Criteria
You may qualify if:
- diagnosis of bipolar I or II disorder (BD), as determined by a structured diagnostic interview
- at least three months of clinical remission (euthymia or minimal symptoms), based on the phone screen assessing mood episodes in the prior three months
- score greater than 11 on a measure of everyday functioning (FAST; described in measures section) indicating at least mild impairment
- use of a standard bipolar mood-stabilizing medication at the same, adequate dose (according to CANMAT treatment guidelines) for at least 3 months prior to screening, with ability to continue that dose during the study.
You may not qualify if:
- history of neurological illness or injury (e.g., stroke, brain tumor)
- documented intellectual disability
- inability to provide written informed consent
- substance dependence within last 3 months or substance abuse in last 30 days
- inability to complete the six-month intervention
- received ECT in the past 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan Depression Center
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sagar Parikh, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry
Study Record Dates
First Submitted
January 11, 2018
First Posted
January 18, 2018
Study Start
November 17, 2017
Primary Completion
December 10, 2018
Study Completion
December 20, 2018
Last Updated
February 28, 2019
Record last verified: 2019-02